Mississauga, ON -- (SBWIRE) -- 11/19/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "DIAGNOS Contracted by Bayer for Diabetic Eye Disease Screening."
Companies mentioned in this article include DIAGNOS Inc. (TSX-Venture:ADK), Bayer (OTC:BAYRY) and KKR & Co. (NYSE:KKR).
Diabetes, a disease that affects some 387 million people globally, is never too far removed from headlines and has found its way back to the front page lately. Researchers led by Salk Institute scientists published a study in Nature detailing their findings in mice studies that show there could be a new type of diabetes not associated with insulin deficiency or obesity. The research, which still is in its infancy and needs evaluation in humans, has led to speculation that millions of Americans over the age of 65 could have this newly identified version, dubbed Type 4 diabetes. On the treatment front, a small study funded by the National Institute of Health found that the impotence drug Viagra improved insulin sensitivity in overweight pre-diabetic people. The study further showed that Viagra was also associated with lowering levels of a biomarker tied to increased risk of heart and kidney disease, two co-morbidities closely linked to diabetes.
As far as detection, Brossard, Quebec-based DIAGNOS Inc. (TSX-Venture:ADK) announced a contract with Bayer (OTC:BAYRY) for macular edema, diabetic retinopathy screening.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.
Investors can receive their free newsletter subscription by clicking here:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp